Blue Owl Technology Finance Corp. heads into its Q1 2026 earnings call — scheduled for May 7 — having already delivered a miss, with the stock nonetheless up 6.4% on the week. That gap between a soft print and a sharply higher price is the defining tension right now.
OTF reported Q1 adjusted EPS of $0.29 after the close on May 6, falling short of the $0.31 consensus estimate. Revenue of $325.9 million also missed the $342.5 million forecast. The reaction may surprise: the stock added 1.5% on May 6 and is up more than 6% over the past five sessions, hitting $11.63. The move suggests the miss was widely anticipated — shorts had been covering aggressively for weeks ahead of the print, and the stock entered the report with meaningful momentum built in.
The lending market tells the clearest story here. Cost to borrow has more than halved over the past five weeks, retreating from a peak above 31% in late March to around 10% now. That compression came alongside a sustained reduction in short positions: estimated shares short have fallen roughly 25% from their late-March highs, dropping from above 9.3 million to 6.7 million. Availability has loosened considerably as well — the borrow pool is far less strained than it was when the 52-week maximum was hit earlier this year. The ORTEX short score has edged down to 52.5 from readings above 55 in late April, consistent with a market that is de-risking the short thesis rather than building on it.
The Street's positioning adds context to the retreat. Citizens maintained a Market Outperform rating on April 22 while trimming its price target to $16 — a cut of roughly 11% but still implying significant upside from current levels. At $11.63, OTF is trading at a P/E of around 8.9x, a valuation that has actually ticked up modestly over the past month as coverage of the macro credit cycle has improved. The dividend-to-price ratio of approximately 12.8% signals that OTF remains a yield-driven name, and that the income floor provides a natural buyer base on dips — which likely explains why the miss did not become a rout.
Institutional ownership warrants a mention this week. The University of California Regents' Endowment holds 9.4% of shares outstanding and reported no change as of February. Mubadala Investment Company holds a further 6.3%, also steady. These are anchor holders with long-duration mandates and low turnover — they provide ballast when credit sentiment softens. Against that, a Bloomberg report on May 1 flagged that Brown University slashed its stake in a Blue Owl private credit fund, a signal that at least some institutional capital is reassessing exposure to the BDC complex more broadly. It is worth watching whether that flows through to OTF directly or stays at the fund level.
The prior earnings print — Q4 2025 in February — resulted in a 1-day move of -1.3% and a 5-day decline of nearly 8%, the latter driven by a broader softening in credit sentiment rather than the print itself. Close peer OBDC managed a more modest 4.8% five-day gain this week, while OWL surged 21% — the parent company benefiting from a broader alternative asset manager re-rating that has lifted the Blue Owl complex. ARCC gained 2.3% and ARES added 8.8%, suggesting the BDC and credit-manager space has had a strong week overall. OTF's 6.4% gain is solid in that context but notably lags OWL, the entity that actually collects management fees on OTF's portfolio.
The Q1 call on May 7 is now the next data point. With the miss already absorbed and short covering likely slowing — shares short have stabilised around 6.7 million over the past two sessions — the focus shifts to management's commentary on credit quality within the technology lending book, net asset value per share, and whether the dividend, currently implying roughly a 12.8% annualised yield at current prices, remains fully covered given the EPS shortfall.
See the live data behind this article on ORTEX.
Open OTF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
